Gladstone NOW: The Campaign Join Us on the Journey ✕
1351 - 1365 of 1367 Results Clear All
SAN FRANCISCO, CA—October 23, 2009—The J. David Gladstone Institutes today announced that Robert Sanders “Sandy” Williams, MD, has been appointed the new president of the Institutes. Dr.
SAN FRANCISCO, CA—October 13, 2009—The National Institutes of Health (NIH) has awarded a “Grand Opportunity” grant of $3.7 million to a consortium formed with the Gladstone Institute of Neurological Disease(GIND) and the Taube-Koret Center for Huntington's Disease Research to use stem cell techno
Huntington’s Disease
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the the Gladstone Institute of Cardiovascular Disease (GICD) and Kyoto University, has won the 2009 Albert Lasker Basic Medical Research Award for his discovery of a method of reprogramming adult skin cells to become embryonic-like stem cells.
SAN FRANCISCO, CA—September 2, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) have traced the evolution of the four-chambered human heart to a common genetic factor linked to the development of hearts in turtles and other reptiles.
SAN FRANCISCO, CA—August 19, 2009—The J. David Gladstone Institutes announced a collaboration with Alitora Systems to develop software technology that facilitates organizational collaboration and enables rapid acceleration of the discovery and evaluation of new drugs.
SAN FRANCISCO, CA, August 14, 2009—The Gladstone Institute of Neurological Disease (GIND) announced that Dena Dubal, MD, PhD, has been named a Beeson Scholar for her research into Alzheimer’s disease.
Awards
SAN FRANCISCO, CA—August 11, 2009—Investor and philanthropist William S. Price III and his wife, Eva, have donated $4.25 million to fund biomedical research programs at The J. David Gladstone Institutes.
SAN FRANCISCO, CA—July 5, 2009—Researchers at the Gladstone Institute of Cardiovascular Disease (GICD) have discovered a key switch that makes stem cells turn into the type of muscle cells that reside in the wall of blood vessels.
SAN FRANCISCO, CA–June 25, 2009–Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have found another clue that may lead to eradication of HIV from infected patients who have been on antiretroviral therapy.
SAN FRANCISCO, CA—April 26, 2009—Scientists at the Gladstone Institute of Cardiovascular Disease (GICD)have identified for the first time key genetic factors that drive the process of generating new heart cells.
SAN FRANCISCO, CA—Shinya Yamanaka, MD, PhD, of the Gladstone Institutes and Kyoto University is one of seven recipients of Canada's prestigious Gairdner Award. The Gairdner is referred to as the “Baby Nobel,” since many winners then go on to win the Nobel Prize.
SAN FRANCISCO, CA—March 25, 2009—The J. David Gladstone Institutes has joined forces with Taube Philanthropies and the Koret Foundation to initiate a groundbreaking research program aimed at preventing, treating, or curing Huntington's disease (HD) by the year 2020.
Huntington’s Disease Taube-Koret Center for Neurodegenerative Disease Research
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes of Cardiovascular Disease (GICD) have found that a key enzyme involved in absorbing fat may also be a key to reducing it.
Metabolism
SAN FRANCISCO, CA—The J. David Gladstone Institutes announced that it has received a major grant from the W.M. Keck Foundation in Los Angeles to establish the Keck Program for Striatal Physiology and Pathophysiology, which will study the origins of movement disorders associated with neurological diseases such as Parkinson's and Huntington's diseases.
SAN FRANCISCO, CA—Researchers at the Gladstone Institute of Cardiovascular Disease (GICD) and the University of California, San Francisco have unraveled a complex signaling process that reveals how different types of cells interact to create a heart.
Srivastava Lab
